Source: Jornal Brasileiro de Pneumologia. Unidade: FMRP
Subjects: DOENÇAS PULMONARES INTERSTICIAIS, FIBROSE PULMONAR
ABNT
PEREIRA, Carlos Alberto de Castro et al. Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil. Jornal Brasileiro de Pneumologia, v. 45, n. 5, p. art. e20180414 [7] , 2019Tradução . . Disponível em: https://doi.org/10.1590/1806-3713/e20180414. Acesso em: 10 nov. 2024.APA
Pereira, C. A. de C., Martinez, J. A. B., Baldi, B. G., Jezler, S. F. de oliveira, Rubin, A. S., Alves, R. L. R., et al. (2019). Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil. Jornal Brasileiro de Pneumologia, 45( 5), art. e20180414 [7] . doi:10.1590/1806-3713/e20180414NLM
Pereira CA de C, Martinez JAB, Baldi BG, Jezler SF de oliveira, Rubin AS, Alves RLR, Zonzin GA, Quaresma M, Trampisch M, Rabahi MF. Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil [Internet]. Jornal Brasileiro de Pneumologia. 2019 ; 45( 5): art. e20180414 [7] .[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/1806-3713/e20180414Vancouver
Pereira CA de C, Martinez JAB, Baldi BG, Jezler SF de oliveira, Rubin AS, Alves RLR, Zonzin GA, Quaresma M, Trampisch M, Rabahi MF. Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil [Internet]. Jornal Brasileiro de Pneumologia. 2019 ; 45( 5): art. e20180414 [7] .[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/1806-3713/e20180414